Effects of P38 MAPK Pathway Inhibition on the Metabolism of Periodontal Ligament Fibroblasts During Inflammation
Journal of Cellular and Molecular Medicine · 2026-06 · 30 (11)
DOI: 10.1111/jcmm.71223 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 01.06.2026. Verfasst von Cheng Qian und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stomatology, Shaoxing Central Hospital, Zhejiang, China. Hauptthemen laut MEDLINE: p38 Mitogen-Activated Protein Kinases, Periodontal Ligament, Fibroblasts, MAP Kinase Signaling System. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hangzhou Municipal Science and Technology Bureau, Hangzhou Municipal Health Commission.
Abstract (Originalsprache)
During the development of periodontitis, osteoclast function is activated by the MAPK pathway. MMPs are able to participate in cross‐activation and self‐activation cascades, thereby modulating gene expression for osteoclast differentiation. Among the MAPK family, the p38 family has a particularly significant impact on the development of chronic inflammation in periodontal tissue. Activation of p38 MAPK signalling directly or indirectly mediates the expression of inflammatory cytokines, thereby synergistically stimulating MMP production. This experiment aims to understand how p38 MAPK affects inflammatory hPDLFs treated with Pseudomonas gingivalis. Compared with the control group, secretion of MMP‐2, −1, and −3 of hPDLFs treated with P. gingivalis ‐LPS was significantly increased and was closely related to the concentration of P. gingivalis ‐LPS. Cell scratching and CCK‐8 experiments revealed that MMP‐1, −2, and −3 inhibited cell proliferation and motility. To explore the signalling pathways involved in p38 MAPK regulation, hPDLFs were treated with P. gingivalis ‐LPS alone or in combination with a p38 MAPK kinase inhibitor. The results suggest that MMP‐1, −2, and −3 can serve as salivary biomarkers for the chronic inflammatory disease periodontitis and regulate inflammation through the p38 MAP kinase pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Stomatology, Shaoxing Central Hospital, Zhejiang, China.
- Department of Stomatology, Shaoxing KEQIAO Women&Children's Hospital, Zhejiang, China.
- School of Stomatology, Hangzhou Normal University, Zhejiang, Hangzhou, China.
- Department of Stomatology, Affiliated Hospital of Hangzhou Normal University, Zhejiang, Hangzhou, China.
ORCID-Profile: Feiyan Gao, Rui He
Förderung
- Hangzhou Municipal Science and Technology Bureau
- Hangzhou Municipal Health Commission
Zitieren
APA
Qian, C., Gu, Y., Gao, F., Xu, Z., Li, J., Liu, S., He, R., Zhong, L., & Wang, J. (2026). Effects of P38 MAPK Pathway Inhibition on the Metabolism of Periodontal Ligament Fibroblasts During Inflammation. Journal of Cellular and Molecular Medicine, 30(11). https://doi.org/10.1111/jcmm.71223
Vancouver
Qian C, Gu Y, Gao F, Xu Z, Li J, Liu S, et al. Effects of P38 MAPK Pathway Inhibition on the Metabolism of Periodontal Ligament Fibroblasts During Inflammation. Journal of Cellular and Molecular Medicine. 2026;30(11). doi:10.1111/jcmm.71223
BibTeX
@article{Qian2026,
author = {Qian, Cheng and Gu, Yifan and Gao, Feiyan and Xu, Zenan and Li, Jiahui and Liu, Shuyu and He, Rui and Zhong, Liangjun and Wang, Jintao},
title = {Effects of P38 MAPK Pathway Inhibition on the Metabolism of Periodontal Ligament Fibroblasts During Inflammation},
journal = {Journal of Cellular and Molecular Medicine},
year = {2026},
volume = {30},
number = {11},
doi = {10.1111/jcmm.71223}
}
EUVIMED